Global identification and quantitative analysis of representative components of Xin-Nao-Kang Capsule, a traditional Chinese medicinal formula, by UHPLC-Q-TOF-MS and UHPLC-TQ-MS

Zhengchao Ji,Yi Jiang,Hua Lin,Wenbo Ren,Lin Lin,Haiyang Guo,Jing Huang,Yanyan Li
DOI: https://doi.org/10.1016/j.jpba.2021.114002
IF: 3.571
2021-05-01
Journal of Pharmaceutical and Biomedical Analysis
Abstract:<p>Xin-Nao-Kang Capsule (XNKC), a well-known traditional Chinese medicine (TCM), is widely used for the treatment of angina pectoris, cerebral arteriosclerosis and coronary artery disease in China. However, the chemical components have not been holistically explored. In this study, a total of 173 chemical components including 48 flavonoids, 8 lactones, 35 acids, 12 phenanthraquinones, 8 monoterpene glycosides, 32 triterpenoids and 30 other compounds were identified, among which 37 were unambiguously characterized in comparison with their corresponding authentic standards using ultra-high performance liquid chromatography coupled with quadruple time-of-flight tandem mass spectrometry (UHPLC-Q-TOF-MS). To further elucidate the major representative constitutes of XNKC, a high performance liquid chromatography coupled with triple quadrupole tandem mass spectrometry (UHPLC-TQ-MS) method was used for simultaneous quantitative analysis of 34 major representative constitutes in ten batches of XNKC samples, which was validated in terms of linearity, precision, accuracy, repeatability and recovery. Meanwhile, the results of chemometric analysis indicated that puerarin and salvianolic acid B might be the most potential quantitative markers for quality control of XNKC. Taken together, the chemical constitutes of XNKC were systematically identified and a reliable quantitative method coupled with chemometric analysis was successfully employed for evaluating the holistic quality of XNKC. This study will provide a robust foundation for the holistic quality assessment of XNKC.</p>
pharmacology & pharmacy,chemistry, analytical
What problem does this paper attempt to address?
The problem that this paper attempts to address is the lack of comprehensive analysis of the chemical components and insufficient quality control research of Xin-Nao-Kang Capsule (XNKC), a traditional Chinese medicine compound preparation. Specifically, although XNKC is widely used in the treatment of angina pectoris, cerebral arteriosclerosis, and coronary artery disease, its chemical components have not been fully explored, and the current quality control methods are limited to the qualitative and quantitative analysis of a few components, which cannot reflect its overall quality. Therefore, the study aims to systematically identify and evaluate the main chemical components in XNKC through high-throughput qualitative and quantitative analysis methods, providing a reliable basis for its overall quality control. To achieve this goal, the researchers used ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF-MS) for qualitative analysis, identifying a total of 173 chemical components, including 48 flavonoids, 8 lactones, 35 acids, 12 anthraquinones, 8 monoterpene glycosides, 32 triterpenoids, and 30 other compounds. In addition, ultra-high-performance liquid chromatography-triple quadrupole mass spectrometry (UHPLC-TQ-MS) was used for quantitative analysis of 34 major representative components. The selection of these components was based on the qualitative and quantitative chemical markers of each medicinal material specified in the "Chinese Pharmacopoeia" (2015 edition), bioactive components with cardiovascular-related activities, and the main characteristic chemical structures of the 16 medicinal materials. Through these methods, the study not only systematically characterized the chemical components of XNKC but also provided a reliable quantitative method for evaluating its intrinsic quality. Combined with chemometric analysis, it laid a solid foundation for the overall quality control of XNKC.